Life Sciences Archives - Page 31 of 34 - Boston Life Sciences Times

Iterative Health Raises $77 Million to Expand Clinical Research Network

April 30, 2026

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

THIS WEEK'S STORIES

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

April 30, 2026

Neurable Shifts to Licensing Model to Expand Brain-Computer Interface Technology

April 28, 2026

Prilenia Therapeutics Names Elisabeth Leiderman as Chief Financial Officer

April 28, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

Veristat to Acquire Certara’s Regulatory and Medical Writing Unit in Expansion Move

Life Science Cares Boston Raises More Than $1 Million at Record-Breaking Event, Calls Industry to Expand Anti-Poverty Efforts

Thermo Fisher Expands Clinical Data Capabilities Through HealthVerity Collaboration

Life Science Cares Boston Marks 10 Years of Impact, Calls Life Sciences Community to Lead Next Decade of Change

Most Read

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Neurable Shifts to Licensing Model to Expand Brain-Computer Interface Technology

Prilenia Therapeutics Names Elisabeth Leiderman as Chief Financial Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US